Abstract:The tumor microenvironment (TME) is a critical determinant in the initiation, progression, and treatment outcomes of various cancers. Comprising of cancer‐associated fibroblasts (CAF), immune cells, blood vessels, and signaling molecules, the TME is often likened to the soil supporting the seed (tumor). Among its constituents, tumor‐associated macrophages (TAMs) play a pivotal role, exhibiting a dual nature as both promoters and inhibitors of tumor growth. This review explores the intricate relationship between TAMs and the TME, emphasizing their diverse functions, from phagocytosis and tissue repair to modulating immune responses. The plasticity of TAMs is highlighted, showcasing their ability to adopt either protumorigenic or anti‐tumorigenic phenotypes based on environmental cues. In the context of cancer, TAMs' pro‐tumorigenic activities include promoting angiogenesis, inhibiting immune responses, and fostering metastasis. The manuscript delves into therapeutic strategies targeting TAMs, emphasizing the challenges faced in depleting or inhibiting TAMs due to their multifaceted roles. The focus shifts towards reprogramming TAMs to an anti‐tumorigenic M1‐like phenotype, exploring interventions such as interferons, immune checkpoint inhibitors, and small molecule modulators. Noteworthy advancements include the use of CSF1R inhibitors, CD40 agonists, and CD47 blockade, demonstrating promising results in preclinical and clinical settings. A significant section is dedicated to Chimeric Antigen Receptor (CAR) technology in macrophages (CAR‐M cells). While CAR‐T cells have shown success in hematological malignancies, their efficacy in solid tumors has been limited. CAR‐M cells, engineered to infiltrate solid tumors, are presented as a potential breakthrough, with a focus on their development, challenges, and promising outcomes. The manuscript concludes with the exploration of third‐generation CAR‐M technology, offering insight into in‐vivo reprogramming and nonviral vector approaches. In conclusion, understanding the complex and dynamic role of TAMs in cancer is crucial for developing effective therapeutic strategies. While early‐stage TAM‐targeted therapies show promise, further extensive research and larger clinical trials are warranted to optimize their targeting and improve overall cancer treatment outcomes.

Macrophages are exploited from an innate wound healing response to facilitate cancer metastasis

The Role of Tumor-Associated Macrophages in Breast Cancer Progression

Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire

Heme catabolism by tumor-associated macrophages controls metastasis formation

A timeline of tumour-associated macrophage biology

Abstract 4699: Pan-cancer single-cell analysis reveals the interactions of SPP1+MMP12+ macrophages with metastasis-initiating cells that drives metastasis

Tumor-associated macrophages: unwitting accomplices in breast cancer malignancy

Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site

Abstract SY37-03: Leveraging the complexities of tumor associated macrophages for effective anti-cancer therapy

Tumor-Associated Macrophages: A Potential Target For Cancer Therapy

Tumor-Associated Macrophages Promote Invasion while Retaining Fc-Dependent Anti-Tumor Function

Macrophages Under the Influence of Tumor Mesothelin Weaken Host Defenses against Pancreatic Cancer Metastasis

Exploring the Tumor Promoting Role of Anti-Tumor Macrophage: a Developmental Perspective

Using a pan-cancer atlas to investigate tumour associated macrophages as regulators of immunotherapy response

The Role of Macrophages in Cancer Development and Therapy

Tumor associated macrophages in breast cancer progression: implications and clinical relevance

Tumour-associated macrophages: versatile players in the tumour microenvironment

From Dichotomy to Diversity: Deciphering the Multifaceted Roles of Tumor-Associated Macrophages in Cancer Progression and Therapy.

From monocyte‐derived macrophages to resident macrophages—how metabolism leads their way in cancer

Macrophages redeploy functional cancer cell surface proteins following phagocytosis

Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression